10x Genomics Cash Flow Statement (2018-2026) | TXG

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-11.05M-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M
Share-based Compensation (Quarter)
26.93M25.95M-47.77M26.05M-9.48M42.10M-35.21M0.28M159.78M36.13M-36.13M108.21M-108.21M31.08M-22.77M75.59M-72.50M22.64M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)
2.79M7.06M2.45M0.60M0.11M
Cash from Operations (Quarter)
3.12M-26.22M5.80M-20.80M-16.96M-9.56M13.72M-4.12M-11.53M-25.30M25.76M-15.72M7.50M21.64M-6.75M34.35M17.71M43.21M40.78M26.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
2.30M1.58M1.54M1.78M1.94M1.96M1.95M2.13M1.94M2.05M1.99M2.30M1.93M1.79M1.81M1.79M1.84M1.95M2.04M
Amortization of Deferred Charges (Quarter)
1.79M1.95M
Depreciation & Amortization (CF) (Quarter)
4.89M5.70M5.78M6.19M6.50M6.16M6.52M6.48M9.94M9.37M9.72M9.19M8.97M8.96M8.75M8.02M7.82M10.30M10.06M9.96M
Change in Working Capital
Change in Receivables (Quarter)
1.64M19.39M6.83M-8.73M-0.30M7.35M20.62M-26.28M9.75M16.16M10.97M-23.52M-0.12M-7.68M4.37M-35.33M-2.59M-6.63M3.23M-7.98M
Change in Inventory (Quarter)
5.60M7.13M8.78M3.74M7.37M8.66M1.43M0.45M1.86M-2.57M-7.61M9.94M5.20M4.26M-9.62M-8.06M-7.03M-7.29M-5.58M-2.70M
Change in Account Payables (Quarter)
-1.17M2.48M-1.11M2.88M7.39M-4.18M-0.22M-0.78M2.10M-4.12M-3.21M4.58M1.12M4.34M-13.40M-2.55M6.04M-0.20M-5.42M4.78M
Change in Accured Expenses (Quarter)
0.70M18.40M4.47M-13.28M5.28M4.84M4.28M-0.16M0.66M8.66M19.15M-12.67M0.55M12.05M3.73M-2.89M5.17M-7.44M-0.61M
Other Working Capital Changes (Quarter)
-0.05M1.44M0.32M3.87M-3.99M-0.30M3.76M10.47M-8.35M1.52M-2.97M2.03M3.80M2.31M-7.06M-2.31M-0.12M0.15M3.04M-1.95M
Investing Activities
Capital Expenditures (Quarter)
-31.35M66.14M27.62M28.14M27.22M36.57M39.73M4.56M4.76M-6.42M45.70M1.90M3.89M3.89M-8.33M1.89M-1.59M-0.17M5.80M0.12M
Acquisitions (Quarter)
1.50M2.50M
Change in Acquisitions & Divestments (Quarter)
12.66M20.04M-15.51M31.93M31.90M63.05M1.19M-13.31M0.57M3.02M0.27M21.93M50.00M-50.00M125.20M25.00M
Cash from Investing Activities (Quarter)
-14.57M-20.23M-27.62M-257.56M-27.53M-32.63M-33.17M119.96M-4.46M4.90M13.10M10.63M11.95M-3.62M-51.59M-1.89M-0.94M-8.80M-1.80M-1.31M
Financing Activities
Other financing activities (Quarter)
7.83M6.36M-8.78M2.40M3.41M8.06M-8.06M1.64M4.60M0.16M4.52M0.42M3.52M0.62M-4.56M0.27M
Cash from Financing Activities (Quarter)
16.19M6.68M8.90M2.42M6.36M2.04M5.00M-3.41M7.10M4.37M5.61M1.64M4.60M0.16M4.52M0.42M3.52M0.62M2.24M-8.42M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
0.01M0.12M-0.08M-0.02M-0.19M-0.09M0.25M0.02M-0.05M-0.09M0.08M-0.05M-0.00M0.16M-0.27M0.11M0.36M-0.03M0.04M-0.07M
Change in Cash (Quarter)
4.75M-39.64M-12.99M-275.96M-38.32M-40.24M-14.20M112.44M-8.94M-16.11M44.55M-3.50M24.04M18.34M-54.09M32.99M20.65M35.00M41.26M16.32M
Free Cash Flow (Quarter)
34.47M-92.36M-21.81M-48.94M-44.18M-46.14M-26.01M-8.68M-16.28M-18.89M-19.94M-17.62M3.61M17.75M1.58M32.46M19.30M43.38M34.98M26.00M
Net Cash Flow (Quarter)
4.75M-39.76M-12.91M-275.94M-38.13M-40.16M-14.45M112.42M-8.89M-16.03M44.47M-3.46M24.05M18.18M-53.82M32.88M20.29M35.03M41.21M16.39M